NovaBridge Biosciences NBP
NASDAQ NBP
$1.38 +0.01 (+1.10%)
As of: Sep 30, 2026 · 10:24 AM EDT

NovaBridge Biosciences (NBP) EV to EBITDA (2024 - 2025)

Updated

NovaBridge Biosciences' (NBP) EV to EBITDA stood at 1.20 in Q3 2025, compared with -2.89 a year earlier.

Analysis

NovaBridge Biosciences (NBP) EV to EBITDA (2024 - 2025) Analysis & Trends

On a TTM basis, NovaBridge Biosciences' EV to EBITDA came in at -3.62 as of Sep 30, 2025.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.20
Dec 31, 2024 -1.63
Sep 30, 2024 -2.89
API Access

NovaBridge Biosciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=NBP&period=max&api_key=YOUR_API_KEY